Cronos Expands Pre-Roll Portfolio with Spinach STIX®
Rhea-AI Summary
Cronos (NASDAQ: CRON) expanded distribution of Spinach STIX®, its first cylindrical-style pre-roll, to eight Canadian provinces on May 6, 2026. The launch targets growing consumer demand for cylindrical pre-rolls, which represented $17 million in March 2026 retail sales and the pre-roll category that accounts for 33%+ of national retail dollar sales.
Spinach STIX® ships in 10x0.4g formats across three strains with advertised THC levels of 24%–26%+ and is positioned as a portable, even-burning pre-roll option.
Positive
- Pre-rolls comprise >33% of Canadian retail cannabis dollar sales
- Cylindrical-style pre-rolls reached $17M in March 2026 national retail sales
- Spinach STIX distribution expanded to 8 Canadian provinces
- Product offered in 3 top-performing strains with 24%–26%+ THC
- 10x0.4g package format aligns with consumer portability preferences
Negative
- None.
News Market Reaction – CRON
On the day this news was published, CRON declined 0.38%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
CRON was down about 0.75% pre-news, while peers were mixed: TLRY -3.72%, AKBA -4.28%, PCRX -1.82%, EVO +0.63%, DVAX +0.06%. This points to stock-specific rather than broad sector dynamics.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Apr 29 | Annual meeting notice | Neutral | -2.6% | Announcement of virtual-only 2026 annual shareholder meeting and logistics. |
| Apr 20 | Earnings call notice | Neutral | +2.6% | Scheduling of Q1 2026 earnings conference call and access details. |
| Mar 16 | Conference presentation | Neutral | +2.2% | CEO participation in the 38th Annual ROTH investor conference. |
| Feb 26 | Earnings & acquisition | Positive | -3.6% | Record Q4 and FY 2025 revenue, improved EBITDA, strong cash, CanAdelaar deal. |
| Feb 17 | Product launch | Positive | +1.9% | Launch of Spinach PUFFERZ™ all-in-one vape with high-THC formulation. |
Operational launches like Spinach PUFFERZ™ saw modest gains, while strong financial results in 2025 Q4 drew a negative reaction, suggesting occasional sell-the-news responses on fundamentals.
Over recent months, Cronos has combined corporate housekeeping with product innovation and financial milestones. The company reported record Q4 2025 net revenue of $44.5M and FY 2025 revenue of $146.6M, plus improved adjusted EBITDA and a sizeable cash position. Yet that update on Feb 26 coincided with a -3.61% move. By contrast, the Spinach PUFFERZ™ launch on Feb 17 saw a modest gain. Today’s Spinach STIX® expansion fits the pattern of brand- and product-focused growth under the Spinach® banner.
Market Pulse Summary
This announcement showcases Cronos’s effort to deepen its Spinach® franchise by entering the cylindrical pre-roll segment, a format tied to more than $17 million in Canadian retail sales in March 2026 and over 33% of category dollars. It follows the Spinach PUFFERZ™ vape launch and record FY 2025 revenue, indicating a strategy centered on high-THC, branded offerings. Investors may watch future earnings for evidence that Spinach STIX® lifts share in key provinces and supports margin performance.
Key Terms
pre-roll technical
indica medical
sativa medical
hybrid medical
AI-generated analysis. Not financial advice.
TORONTO, May 06, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, announced today that Spinach STIX®, its latest innovation in its popular line-up of Spinach® pre-rolls, is now available in more provinces across Canada. Spinach STIX® is the brand’s first cylindrical-style pre-roll, designed to meet surging consumer interest in this highly sought-after format in the pre-roll category1.
The pre-roll category remains one of the largest and most popular in the Canadian cannabis market, accounting for more than
“Introducing Spinach STIX® into more provinces across Canada allows us to meet evolving consumer preferences by offering an alternative, sleek pre-roll option for consumers to enjoy the strains they love most from our portfolio,” said Mike Gorenstein, Chairman, President and CEO of Cronos. “We remain focused on optimizing our lineup of fantastic, high-quality products that have made Spinach® one of the top and most reliable cannabis brands in Canada.”
Spinach STIX® are available in the following curated selection of Cronos’ top-performing strains:
- Spinach STIX® GMO Cookies
- The Spinach® brand’s #1 flower strain, featuring sweet and savory flavor notes
- Indica | THC:
25% + | 10x0.4g
- Spinach STIX® Sour Chem
- Featuring classic gasoline, chemical, and zesty citrus notes
- Sativa | THC:
26% + | 10x0.4g
- Featuring classic gasoline, chemical, and zesty citrus notes
- Spinach STIX® Space Cake
- Featuring berry, nutty, and citrusy flavors
- Hybrid | THC:
24% + | 10x0.4g
Spinach STIX® pre-rolls are available now in Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland, Nova Scotia, Ontario, and Saskatchewan. For more information and product availability, visit https://spinachcannabis.com/. To learn more about Spinach STIX® and to stay up-to-date on Spinach® products, follow @spinachwithfriends on Instagram.
1Hifyre Retail Analytics - National Retail Dollars – March 2026
About Cronos Group Inc.
Cronos is an innovative global cannabis company focused on scaling leading consumer goods products through R&D and innovation. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS®, LIT®, and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.
Forward-looking Statements
This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about expanded availability of Spinach STIX® across Canadian provinces; continued consumer demand for cylindrical-style pre-rolls and the pre-roll category generally; anticipated consumer response to Spinach STIX® and its design attributes; the Company’s intent to meet evolving consumer preferences through product format innovation; the Company’s focus on expanding and refining the Spinach® product lineup; the continued positioning of Spinach® as a top and reliable cannabis brand in Canada; the Company's innovation strategy and development of high-quality consumer goods products; and Cronos’ intention to build an international iconic brand portfolio and develop disruptive intellectual property by advancing cannabis research, technology and product development. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks. Financial results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, which has been filed on SEDAR+ and EDGAR and can be accessed at www.sedarplus.ca and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.
For further information, please contact:
Media Relations Contact:
Emily Whalen
Communications
Tel: (416) 504-0004
media.relations@thecronosgroup.com
Investor Relations Contact:
Harrison Aaron
Investor Relations
Tel: (416) 504-0004
investor.relations@thecronosgroup.com
